HORIZON-HLTH-2027-01-DISEASE-08
Development of innovative antimicrobials against pathogens resistant to antimicrobials
44 200 000
HORIZON Research and Innovation Actions
10/02/2027
13/04/2027
331 jours
HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03
Tools and technologies to support health adaptation to climate change
20 000 000
HORIZON Pre-commercial Procurement
10/02/2027
13/04/2027
331 jours
HORIZON-HLTH-2027-01-ENVHLTH-02
Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change
45 000 000
HORIZON Research and Innovation Actions
10/02/2027
13/04/2027
331 jours
HORIZON-HLTH-2027-01-CARE-02
Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
38 000 000
HORIZON Research and Innovation Actions
10/02/2027
13/04/2027
331 jours
HORIZON-HLTH-2027-01-STAYHLTH-01
Addressing disabilities through the life course to support independent living and inclusion
39 300 000
HORIZON Research and Innovation Actions
10/02/2027
13/04/2027
331 jours
HORIZON-HLTH-2027-01-DISEASE-05
Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
44 200 000
HORIZON Research and Innovation Actions
10/02/2027
13/04/2027
331 jours
HORIZON-HLTH-2027-01-DISEASE-07
Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
37 300 000
HORIZON Research and Innovation Actions
10/02/2027
13/04/2027
331 jours
HORIZON-HLTH-2027-01-DISEASE-06
Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
37 300 000
HORIZON Research and Innovation Actions
10/02/2027
13/04/2027
331 jours
HORIZON-HLTH-2027-01-IND-01
Development of cell-free protein synthesis platforms for discovery and/or production of biologicals
24 500 000
HORIZON Research and Innovation Actions
10/02/2027
13/04/2027
331 jours
HORIZON-HLTH-2027-01-DISEASE-10
Prevention and management of chronic non-communicable diseases in children and young people (GACD)
11 800 000
HORIZON Research and Innovation Actions
10/02/2027
13/04/2027
331 jours
Topic(s)
Development of innovative antimicrobials against pathogens resistant to antimicrobials
Clôture :
13/04/2027
Clôture (2nde étape) :
Tools and technologies to support health adaptation to climate change
Clôture :
13/04/2027
Clôture (2nde étape) :
Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change
Clôture :
13/04/2027
Clôture (2nde étape) :
Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Clôture :
13/04/2027
Clôture (2nde étape) :
Addressing disabilities through the life course to support independent living and inclusion
Clôture :
13/04/2027
Clôture (2nde étape) :
Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
Clôture :
13/04/2027
Clôture (2nde étape) :
Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
Clôture :
13/04/2027
Clôture (2nde étape) :
Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
Clôture :
13/04/2027
Clôture (2nde étape) :
Development of cell-free protein synthesis platforms for discovery and/or production of biologicals
Clôture :
13/04/2027
Clôture (2nde étape) :
Prevention and management of chronic non-communicable diseases in children and young people (GACD)
Clôture :
13/04/2027
Clôture (2nde étape) :